Regeneron Pharmaceuticals (NQ: REGN )
1,071.70
+8.10
(+0.76%)
Streaming Delayed Price
Updated: 2:52 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals![]() ![]() ![]()
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
![]() ![]()
Earnings Outlook For Regeneron Pharmaceuticals
February 01, 2024
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|